$AMBQ

Chen Timothy sold $266K of AMBQ (indirect holdings)

Chen Timothy sold 3,264 indirectly-held shares of Ambiq Micro, Inc. (AMBQ) at $81.57 ($0.27M total) on 2026-05-27.

Original reporting
SEC EDGAR · Chen Timothy
Published May 29, 2026, 11:51 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 29, 2026, 11:56 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$AMBQ
Neutral
medium confidence
Mentioned
$AMBQ
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AMBQNeutralLow
01

Why it matters

This provides a datapoint on insider behavior but does not introduce new company fundamentals or external catalysts.

02

Market read

Traders may monitor for follow-on insider activity, but the filing alone is unlikely to drive a major repricing.

03

What to watch

Insider sales are often scheduled or tax-driven; without context on total holdings history or compensation structure, directional inference is weak.

Relevance 6/10Novelty 6/10Timing: Filed May 29; sale executed May 27 (after market close timing not specified).

Background

The article is an SEC EDGAR Form 4 insider transaction disclosure for Ambiq Micro, Inc.

Company-level read

Ticker impact

$AMBQNeutralMedium confidence
Context

Ambiq Micro director Chen Timothy sold 3,264 shares in an open-market transaction disclosed via SEC Form 4.

Expected impact

Low likelihood of a sustained price move solely from this Form 4; any reaction is likely brief.

Evidence & confidence

The filing is an ownership-change disclosure with no stated reason, no 10b5-1 plan, and no accompanying company-specific news (earnings, guidance, deal, or regulatory action).

Market effects

Limited read-through to the semiconductor/IoT chip space; this is company-specific insider activity without broader sector news.

None indicated.

None indicated.

Counterpoint

The sale could be routine liquidity/portfolio rebalancing rather than a negative view on fundamentals, especially given the director role and lack of stated rationale.

Key entities

  • Ambiq Micro, Inc.

    Subject of the insider transaction disclosure; director Chen Timothy sold shares.

  • Chen Timothy

    Director who executed the open-market sale of 3,264 shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

Med

Ambiq Micro, Inc. Q2 2026 Earnings Call Summary

Ambiq Micro reported Q2 2026 results and said revenue rose 90% year over year, driven by stronger Edge AI demand and growth across Apollo II and Apollo IV, with Apollo V more than doubling on a new large customer ramp. Management projected Q3 net sales up ~100% YoY and 2026 revenue about $135M, despite supply constraints limiting shipments. Gross margin expected to improve modestly in 2026.

Med

Ambiq Micro Q2 net loss narrows to US$7.1 million as edge AI sales surge

Ambiq Micro reported Q2 net loss of $7.1 million, or $0.32 per share, narrowing from $8.5 million a year earlier, as revenue rose 89.7% on stronger demand for ultra-low power edge AI chips. Q2 gross profit more than doubled to $15.3 million and gross margin rose to 45%. H1 net loss was $17.3 million. Cash was $366.8 million after a June follow-on raising $167.9 million net proceeds.

$AMBQHighAI 9/10

Ambiq (AMBQ) Q2 2026 Earnings Call Transcript

Ambiq Micro (AMBQ) reported Q2 2026 net sales of $33.9 million, up 89.7% year over year, citing accelerating edge AI demand. Non-GAAP gross margin was 47.2%. Full-year net sales guidance is about $135 million, with Q3 revenue outlook of $36 million to $37 million. Management cited supply constraints limiting order fulfillment and said cash was $366.8 million as of June 30, 2026.